bromouracil has been researched along with Bone Marrow Diseases in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
Bone Marrow Diseases: Diseases involving the BONE MARROW.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okuda, H | 1 |
| Nishiyama, T | 1 |
| Ogura, K | 1 |
| Nagayama, S | 1 |
| Ikeda, K | 1 |
| Yamaguchi, S | 1 |
| Nakamura, Y | 1 |
| Kawaguchi, K | 1 |
| Watabe, T | 1 |
| Ogura, Y | 1 |
1 other study available for bromouracil and Bone Marrow Diseases
| Article | Year |
|---|---|
Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Arabinofuranosylur | 1997 |